DE1816049A1 - Antimalaria-Mittel - Google Patents

Antimalaria-Mittel

Info

Publication number
DE1816049A1
DE1816049A1 DE19681816049 DE1816049A DE1816049A1 DE 1816049 A1 DE1816049 A1 DE 1816049A1 DE 19681816049 DE19681816049 DE 19681816049 DE 1816049 A DE1816049 A DE 1816049A DE 1816049 A1 DE1816049 A1 DE 1816049A1
Authority
DE
Germany
Prior art keywords
salts
substance
weight
proguanil
cycloguanil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19681816049
Other languages
German (de)
English (en)
Inventor
Dr Michel Fernex
Dr Jose Herrero
Dr Alfred Rheiner Jun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE1816049A1 publication Critical patent/DE1816049A1/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19681816049 1968-01-24 1968-12-20 Antimalaria-Mittel Pending DE1816049A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH110068 1968-01-24
CH445668 1968-03-26
US7659370A 1970-09-29 1970-09-29

Publications (1)

Publication Number Publication Date
DE1816049A1 true DE1816049A1 (de) 1969-11-27

Family

ID=27172694

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681816049 Pending DE1816049A1 (de) 1968-01-24 1968-12-20 Antimalaria-Mittel

Country Status (8)

Country Link
US (1) US3674872A (US07224749-20070529-P00002.png)
BE (1) BE727291A (US07224749-20070529-P00002.png)
DE (1) DE1816049A1 (US07224749-20070529-P00002.png)
FR (1) FR2000647A1 (US07224749-20070529-P00002.png)
GB (1) GB1180204A (US07224749-20070529-P00002.png)
NL (1) NL6817526A (US07224749-20070529-P00002.png)
OA (1) OA03960A (US07224749-20070529-P00002.png)
SE (1) SE362013B (US07224749-20070529-P00002.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) 1992-11-26 1993-01-13 Wellcome Found Medicaments

Also Published As

Publication number Publication date
GB1180204A (en) 1970-02-04
NL6817526A (US07224749-20070529-P00002.png) 1969-07-28
US3674872A (en) 1972-07-04
OA03960A (fr) 1979-08-31
BE727291A (US07224749-20070529-P00002.png) 1969-07-23
SE362013B (US07224749-20070529-P00002.png) 1973-11-26
FR2000647A1 (fr) 1969-09-12

Similar Documents

Publication Publication Date Title
DE2331793C3 (US07224749-20070529-P00002.png)
DE2513797C2 (de) Pharmazeutische zusammensetzung
DE3751761T2 (de) Penetrationsverbesserer für die transdermale Verabreichung von systemisch wirksamen Arzneimitteln
DE3115080A1 (de) Arzneimittel fuer die orale verabreichung und verfahren zu seiner herstellung
DE2208787B2 (de) Mittel zur Behandlung von Herpes-Virusinfektionen
DE3418820A1 (de) Arzneimittel fuer verdauungsgeschwuer
EP0224810B1 (de) Antihypertensives Kombinationspräparat
DE3408362A1 (de) Arzneimittel mit antineoplastischer wirkung
DE69308762T2 (de) Behandlung des Muskulschwunds
DE2528460A1 (de) Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
DE1808948A1 (de) Schmerzlos injizierbares Arzneimittelgemisch
DE3234537A1 (de) Arzneimittel zur behandlung kardiovaskulaerer erkrankungen
DE1816049A1 (de) Antimalaria-Mittel
DE2625053C3 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
DE69910738T2 (de) Fungizide zusammensetzung enthaltend ein n-benzoyl-n'-phenyl-harnstoff derivat
AT408719B (de) Mittel zur behandlung von hepatitis c
DE2314387C3 (de) Arzneimittel zur Behandlung bösartiger Neubildungen
Groh et al. ORALE DAUERTHERAPIE MIT CLONAZEPAM (Ro 5‐4023) BEI EPILEPSIEN DES KINDES‐UND JUGENDALTERS
EP0342565A2 (de) Verwendung des Thiazol-Derivates Tiprotimod zur Herstellung eines Mittels zur Therapie von Virusinfektionen
DE2137045A1 (de) Arzneimittelzubereitung
DE3780702T2 (de) Verwendung von etodolac zur senkung des blutgehalts an harnsaeure.
EP0152860B1 (de) Verwendung von Cephemverbindungen zur Herstellung eines Arzneimittels für die Modulation des Immunsystems
DE2844534C2 (US07224749-20070529-P00002.png)
DE3424279A1 (de) Verwendung von mini-somatostatinen fuer die behandlung der senilen demenz
DE2110537A1 (de) Furoyl-N-pyridylamide und Verfahren zu deren Herstellung